EUVIMEDEUVIMED entdecken
Kontrollierte klinische StudieMultizentrische StudieOpen Access · CC BY 4.0

Wellbeing While Waiting: Effectiveness and implementation of youth social prescribing for young people awaiting CAMHS support

Daniel Hayes, Joely Wright, Alexandra Burton, Feifei Bu, Lou Sticpewich, Het Stuttard, Joanna Page, Alexandra Bradbury, Emeline Han, Jessica Deighton, Marc S Tibber, Shivangi Talwar und 1 weitere

European Child & Adolescent Psychiatry · 2026

DOI: 10.1007/s00787-026-03074-8 ↗

Kurz gefasst

Kontrollierte klinische Studie in der Zeitschrift European Child & Adolescent Psychiatry, 2026. Verfasst von Daniel Hayes und 12 weiteren Autor:innen. Beteiligte Einrichtung: Social Biobehavioural Research Group, Institute of Epidemiology & Health Care, University College London, London, United Kingdom. d.hayes@ucl.ac.uk. Hauptthemen laut MEDLINE: Adolescent Health Services, Mental Health Services, Social Prescribing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Economic and Social Research Council, Wellcome Trust, National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prolonged waiting times for Child and Adolescent Mental Health Services (CAMHS) leave many young people without structured support while awaiting specialist treatment. Social prescribing has been proposed as a community-based adjunct within CAMHS pathways; however, evidence regarding its safety and clinical impact remains limited. Wellbeing While Waiting was a multi-site non-randomised controlled trial embedded within a hybrid type II implementation–effectiveness evaluation conducted across 11 CAMHS in England. The protocol was prospectively published prior to recruitment (BMC Psychiatry; https://doi.org/10.1186/s12888-023-04758-0 ). Between May 2023 and March 2025, 558 young people aged 11–18 years referred to CAMHS were enrolled (225 usual care; 333 social prescribing). Primary outcomes were anxiety and depression symptoms, total emotional and behavioural difficulties, and perceived stress. Secondary outcomes included resilience and wellbeing. No intervention-related adverse events were observed. On average, participants had 5 sessions with a Link Worker. Compared with usual care, no significant differences were observed in anxiety or depression symptoms. However, participants receiving social prescribing demonstrated significant improvements in total emotional and behavioural difficulties over six months, driven by reductions in conduct difficulties, hyperactivity and peer problems. Significant improvements for those receiving social prescribing were also found for prosocial behaviour and resilience. Within routine CAMHS pathways, no intervention-related adverse events were observed for social prescribing, and social prescribing was associated with improvements in behavioural and resilience-related outcomes, although not in anxiety or depressive symptoms. Findings suggest social prescribing may offer a valuable adjunct during delayed access to specialist treatment, with effects distinct from symptom-focused clinical therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adolescent Health ServicesMental Health ServicesSocial PrescribingAdolescentChildFemaleHumansMaleAnxietyDepressionEnglandPsychological Well-BeingResilience, PsychologicalWaiting Lists

Stichwörter der Autor:innen

CAMHSControlled trialMental healthResilienceSocial prescribing

Autor:innen und Institutionen

  • Social Biobehavioural Research Group, Institute of Epidemiology & Health Care, University College London, London, United Kingdom. d.hayes@ucl.ac.uk.
  • Social Biobehavioural Research Group, Institute of Epidemiology & Health Care, University College London, London, United Kingdom.
  • Centre for Psychiatry and Mental Health, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.
  • Evidence Based Practice Unit, Anna Freud National Centre for Children and Families and University College London, London, United Kingdom.
  • Research Department of Clinical, Educational and Health Psychology, Division of Psychology and Language Sciences, University College London, London, United Kingdom.
  • Division of Psychiatry, University College London, Maple House, Gower Street, London, United Kingdom.

Förderung

  • Economic and Social Research Council
  • Wellcome Trust
  • National Institute for Health and Care Research
  • The Prudence Trust

Zitieren

APA

Hayes, D., Wright, J., Burton, A., Bu, F., Sticpewich, L., Stuttard, H., Page, J., Bradbury, A., Han, E., Deighton, J., Tibber, M. S., Talwar, S., & Fancourt, D. (2026). Wellbeing While Waiting: Effectiveness and implementation of youth social prescribing for young people awaiting CAMHS support. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-026-03074-8

Vancouver

Hayes D, Wright J, Burton A, Bu F, Sticpewich L, Stuttard H, et al. Wellbeing While Waiting: Effectiveness and implementation of youth social prescribing for young people awaiting CAMHS support. European Child & Adolescent Psychiatry. 2026. doi:10.1007/s00787-026-03074-8

BibTeX
@article{Hayes2026,
  author = {Hayes, Daniel and Wright, Joely and Burton, Alexandra and Bu, Feifei and Sticpewich, Lou and Stuttard, Het and Page, Joanna and Bradbury, Alexandra and Han, Emeline and Deighton, Jessica and Tibber, Marc S and Talwar, Shivangi and Fancourt, Daisy},
  title = {Wellbeing While Waiting: Effectiveness and implementation of youth social prescribing for young people awaiting CAMHS support},
  journal = {European Child & Adolescent Psychiatry},
  year = {2026},
  doi = {10.1007/s00787-026-03074-8}
}
Kostenlos starten →